Research Paper Advance Articles pp 24228—24241

The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction

Figure 7. Gene set enrichment analyses. (AC) Top 3 (HOXC6 target cancer, intestine probiotics, target of SMAD2 or SMAD3.) oncological signatures significantly C2 (hallmark gene sets) enriched in the high-risk group identified by gene set enrichment analysis. (DF) Top 3 (nuclear periphery, apical junction assembly, nuclear matrix.) oncological signatures significantly C5 (biological process) enriched in the high-risk group identified by gene set enrichment analysis. (GI) Top 3 (MTORC1 signaling, glycolysis, unfolded protein response.) oncological signatures significantly H (hallmark gene sets) enriched in the high-risk group identified by gene set enrichment analysis.